Medtronic announces cash dividend for fourth quarter of fiscal year 2025

Rhea-AI Summary

Medtronic (NYSE: MDT) has declared a quarterly cash dividend of $0.70 per ordinary share for the fourth quarter of fiscal year 2025. The dividend will be paid on April 11, 2025, to shareholders of record as of March 28, 2025.

This declaration aligns with the dividend increase announced in May 2024. As a member of the S&P 500 Dividend Aristocrats index, Medtronic has maintained a 47-year streak of consecutive annual dividend increases.

Headquartered in Galway, Ireland, Medtronic is a global healthcare technology company with 95,000+ employees across more than 150 countries. The company develops technologies and therapies for 70 health conditions, including cardiac devices, surgical robotics, insulin pumps, surgical tools, and patient monitoring systems.

Positive

• 47-year track record of consecutive dividend increases
• Maintains position in S&P 500 Dividend Aristocrats index
• Stable quarterly dividend of $0.70 per share
• Global presence in 150+ countries

Negative

• None.

Insights

Financial Analyst

Medtronic's declaration of a $0.70 quarterly dividend maintains its established payout level and reinforces the company's 47-year streak of consecutive annual dividend increases. This remarkable consistency places MDT among the elite S&P 500 Dividend Aristocrats - a distinction achieved by fewer than 65 public companies.

While this quarterly announcement doesn't represent a new increase (those typically occur in May annually), it confirms Medtronic's unwavering commitment to shareholder returns despite evolving market conditions. At the current share price, this translates to an annualized yield of approximately 3.0%, providing meaningful income in today's market environment.

The dividend aristocrat status speaks volumes about Medtronic's long-term financial stability and cash flow generation capabilities. Maintaining this status requires not just financial discipline but also sustainable business performance across multiple economic cycles and healthcare industry transformations.

For income-focused investors, particularly those in retirement portfolios, this predictable quarterly payment (scheduled for April 11 to shareholders of record on March 28) represents exactly the kind of reliability that makes dividend aristocrats cornerstone holdings. The 47-year growth streak demonstrates management's prioritization of consistent shareholder returns alongside the company's ongoing investments in healthcare technology innovation.

GALWAY, Ireland, March 6, 2025 /PRNewswire/ -- The board of directors of Medtronic plc (NYSE: MDT) on Thursday, March 6, 2025, approved the company's cash dividend for the fourth quarter of fiscal year 2025 of $0.70 per ordinary share. This quarterly declaration is consistent with the dividend increase announcement made by the company in May 2024. Medtronic is a constituent of the S&P 500 Dividend Aristocrats index, having increased its annual dividend payment for the past 47 consecutive years. The dividend is payable on April 11, 2025, to shareholders of record at the close of business on March 28, 2025.

About Medtronic
Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic, visit www.Medtronic.com and follow Medtronic on LinkedIn.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

Contacts:
Erika Winkels	Ryan Weispfenning
Public Relations	Investor Relations
+1-763-526-8478	+1-763-505-4626

 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/medtronic-announces-cash-dividend-for-fourth-quarter-of-fiscal-year-2025-302395131.html

SOURCE Medtronic plc

FAQ

What is the Q4 2025 dividend amount for Medtronic (MDT) stock?

Medtronic's Q4 2025 dividend is $0.70 per ordinary share, payable on April 11, 2025.

When is the record date for Medtronic's (MDT) Q4 2025 dividend?

The record date is March 28, 2025, for shareholders to be eligible for the Q4 2025 dividend payment.

How many consecutive years has Medtronic (MDT) increased its dividend?

Medtronic has increased its annual dividend payment for 47 consecutive years, making it an S&P 500 Dividend Aristocrat.

What is Medtronic's (MDT) global workforce size in 2025?

Medtronic employs over 95,000 people across more than 150 countries globally.